These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28155607)

  • 21. A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer.
    Hochhertz F; Hass P; Röllich B; Ochel HJ; Gawish A
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5743-5749. PubMed ID: 36566484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
    Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
    Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study.
    Mi Y; Lv P; Wang F; Li L; Zhu M; Wang Y; Zhang Y; Liu L; Cao Q; Dong M; Shi Y; Fan R; Li J; Gu Y; Zuo X
    Front Oncol; 2020; 10():550327. PubMed ID: 33134162
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
    Fastner G; Hauser-Kronberger C; Moder A; Reitsamer R; Zehentmayr F; Kopp P; Fussl C; Fischer T; Deutschmann H; Sedlmayer F
    Strahlenther Onkol; 2016 Jan; 192(1):1-7. PubMed ID: 26403912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative Radiation Therapy (IORT): A Series of 1000 Tumors.
    Silverstein MJ; Epstein M; Kim B; Lin K; Khan S; Snyder L; Guerra L; Coleman C; Chen P
    Ann Surg Oncol; 2018 Oct; 25(10):2987-2993. PubMed ID: 29968030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer.
    Abo-Madyan Y; Welzel G; Sperk E; Neumaier C; Keller A; Clausen S; Schneider F; Ehmann M; Sütterlin M; Wenz F
    Strahlenther Onkol; 2019 Jul; 195(7):640-647. PubMed ID: 30796496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.
    Valente SA; Tendulkar RD; Cherian S; Shah C; Ross DL; Lottich SC; Laronga C; Broman KK; Donnelly ED; Bethke KP; Shaw C; Lockney NA; Pederson A; Rudolph R; Hasselle M; Kelemen P; Hermanto U; Ashikari A; Kang S; Hoefer RA; McCready D; Fyles A; Escallon J; Rohatgi N; Graves J; Graves G; Willey SC; Tousimis E; Riley L; Deb N; Tu C; Small W; Grobmyer SR
    Ann Surg Oncol; 2021 May; 28(5):2512-2521. PubMed ID: 33433786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative radiotherapy: An alternative to whole-breast external beam radiotherapy in the management of highly selective breast cancer: A SEER database analysis.
    Sun D; Lu G; Liang F; Zhang W; Zeng T; Ling Y; Peng H; Xia T; Hu M; Chen X
    Cancer Med; 2024 Aug; 13(16):e7458. PubMed ID: 39157891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.
    Corica T; Nowak AK; Saunders CM; Bulsara M; Taylor M; Vaidya JS; Baum M; Joseph DJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):55-64. PubMed ID: 27511847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
    Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative Radiotherapy as a Tumour-Bed Boost Combined with Whole Breast Irradiation Versus Conventional Radiotherapy in Patients with Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    He J; Chen S; Ye L; Sun Y; Dai Y; Song X; Lin X; Xu R
    Ann Surg Oncol; 2023 Dec; 30(13):8436-8452. PubMed ID: 37507556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First Intraoperative Radiation Therapy Center in Africa: First 2 Years in Operation, Including COVID-19 Experiences.
    Ramdas Y; Benn CA; van Heerden M
    JCO Glob Oncol; 2020 Nov; 6():1696-1703. PubMed ID: 33156717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.
    Valente SA; Tendulkar RD; Cherian S; O'Rourke C; Greif JM; Bailey L; Uhl V; Bethke KP; Donnelly ED; Rudolph R; Pederson A; Summer T; Lottich SC; Ross DL; Laronga C; Loftus L; Abbott AM; Kelemen P; Hermanto U; Friedman NB; Bedi GC; Joh JE; Thompson WA; Hoefer RA; Wilson JP; Kang SK; Rosen B; Ruffer J; Bravo L; Police A; Escallon JM; Fyles AW; McCready DR; Graves GM; Rohatgi N; Eaker JA; Graves J; Willey SC; Tousimis EA; Collins BT; Shaw CM; Riley L; Deb N; Kelly T; Andolino DL; Boisvert ME; Lyons J; Small W; Grobmyer SR
    Ann Surg Oncol; 2016 Sep; 23(9):2809-15. PubMed ID: 27160524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer.
    Broman K; Sun W; Zhou JM; Fridley B; Diaz R; Laronga C
    Am J Surg; 2019 Oct; 218(4):749-754. PubMed ID: 31345502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.
    Masuda H; Brewer TM; Liu DD; Iwamoto T; Shen Y; Hsu L; Willey JS; Gonzalez-Angulo AM; Chavez-MacGregor M; Fouad TM; Woodward WA; Reuben JM; Valero V; Alvarez RH; Hortobagyi GN; Ueno NT
    Ann Oncol; 2014 Feb; 25(2):384-91. PubMed ID: 24351399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
    Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
    BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
    Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
    Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.